Related Experiment Video
Updated: Mar 6, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
[How will artificial intelligence improve cardiovascular prevention?]
Andrei Alexandru Mircea1,2, Emmanuel Abbé3, Adèle Mackowiak2
1Centre de médecine générale et santé publique, Unisanté, 1010 Lausanne.
None:
Artificial intelligence (AI) is no longer just a passing trend. It is slowly becoming an integral part of our daily lives and our medical practice. AI opens new avenues for improving the cardiovascular prevention field. This article describes two viewpoints: a) how AI helps the patient to manage his/her cardiovascular risk factors and to educate himself/herself and b) how AI helps clinicians to improve their clinical practice. The day-to-day clinical practice already integrates smartwatches and large language models. Meanwhile, risk scores using machine learning and genetic data are still in the validation process.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease I: Introduction

